Monday, February 6, 2023 | Back issues
Courthouse News Service Courthouse News Service

Snake Oil

The Federal Trade Commission sued Zycal Bioceuticals Healthcare Co., et al., in federal court, for claiming that its Ostinol (Cyplexinol) drug causes osteoporosis patients to grow new bone and cartilage.

BOSTON — The Federal Trade Commission brought a federal complaint against Zycal Bioceuticals Healthcare Co., et al., for claiming that its Ostinol (Cyplexinol) drug causes osteoporosis patients to grow new bone and cartilage.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...